Newsroom
Category
October 2, 2024
Female cancer patients at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, have a new option to preserve their fertility before undergoing treatment. “It is extremely common that cancer patients will experience the loss of fertility and early menopause after gonadotoxic therapies required for many cancer patients,” said […]
October 1, 2024
Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse. By 2030, pancreatic cancer is expected […]
September 19, 2024
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was recently awarded a $12.6 million program project grant (P01) from the National Institutes of Health’s National Cancer Institute to expand collaborative efforts to explore the biological mechanisms of BRCA1, BRCA2 and related tumor suppressors and to shed light on potential […]
September 3, 2024
Lei Zheng, MD, PhD, alumnus of The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has been appointed executive director of Mays Cancer Center at UT Health San Antonio and vice president for oncology for the health science center, effective Sept. 1, 2024. Zheng will also be named the Mays Family Foundation Distinguished […]
August 23, 2024
As part of the $52 million Cancer Prevention and Research Institute of Texas (CPRIT) grant funding round announced in May, The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received a $2 million CPRIT recruitment (CPRIT Scholar) funding award to bring top cancer researcher, Maria Falzone, PhD, to the […]
August 8, 2024
A drug effective in treating breast cancer shows new promise in addressing breast cancer with brain metastases or recurrent glioblastoma, as reported by results of a prospective window-of-opportunity trial at the University of Texas Health Science Center at San Antonio (UT Health San Antonio). The window trial, in which patients agreed to receive a novel […]
